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SEVERAL ANIMAL MODELS OF FETAL and placental growth restriction (e.g., maternal nutritional plane, maternal age, heat stress, hypoxic stress, and fetal number) have been developed to better unravel the relationship between uteroplacental blood flow, placental vascularity, and nutrient delivery to the fetus (27, 45, 48, 56, 61) . In sheep, increasing uterine blood flow during the last half of gestation is vital for maintaining continual delivery of sufficient oxygen and nutrients to the exponentially growing fetus (18, 33, 43, 48, 49) . Animal models of compromised pregnancies have shown aberrations in uterine blood flow and placental vascularity, which is highly associated with the magnitude of fetal growth restriction. In addition, compromised pregnancies show a decrease in umbilical cord blood flow, which is due to a drop in umbilical blood flow velocity (51) . Moreover, increased umbilical arterial pulsatility index and resistance index, which is contingent upon increased placental vascular resistance, are evident in both human and sheep compromised pregnancies (14, 19, 58) . Low birth weight offspring from compromised pregnancies have increased incidences of adult onset diseases (6) , poor growth rates, and lower daily rates of gross energy accretion (23) . Older lambs born to nutrient-restricted dams showed altered nephron number and greater mean arterial blood pressure compared with control lambs (20) . Similar to the hypertension associated with older lambs born to nutrient-restricted dams, several studies indicate an increased risk of cardiovascular disease in adult animals subjected to intrauterine growth restriction. These alterations in cardiovascular function are apparent in the developing fetus, where maternal nutrient restriction increased both fetal heart left and right ventricular weights compared with control fetuses (59) . Growth-restricted fetuses at day 130 of gestation showed altered fetal coronary artery vasoconstriction to angiotensin II and altered fetal cardiomyocyte binucleation in the left ventricle (9) . Therefore, intrauterine growth restriction during late gestation can alter the vasoreactivity of coronary arteries and cardiomyocyte maturation, enlargement, and proliferation in fetal sheep, which may be indicative of later life cardiovascular dysfunction.
The amplitude of melatonin secretion has been associated with improved oxidative status and altered steroid and prostaglandin metabolism in rats and sheep, as well as altered cardiovascular function (2, 16, 26, 60) . Melatonin supplementation during a compromised pregnancy may increase uteroplacental blood flow either directly through melatonergic receptor-dependent pathways or indirectly by decreasing oxidative stress in placental vascular beds (26, 41) . In addition, melatonin has been shown to partially modulate blood pressure, myocardial contractility, and arterial vasoconstriction and vasodilation (41) . Melatonin may influence peripheral vascular resistance via melatonin receptors, which have been discovered throughout the cardiovascular system, including both endothelial and vascular smooth muscle cells (41) . However, the direct effect of melatonin on in vitro vascular reactivity remains controversial due to the contradictory results from several laboratories (35) . Apart from these cardiovascular effects, melatonin supplementation may increase nutrient absorption in the gastrointestinal tract by decreasing intestinal speed of food transit time (10) or decrease maternal nutrient utilization by decreasing locomotor activity (22) . Interestingly, decreased scotophase concentrations of melatonin have been associated with severely compromised pregnancies in humans (38) . Therefore, supplementing melatonin may improve fetal growth in a compromised pregnancy; however, apart from characterizing diurnal secretions of melatonin throughout gestation, a paucity of information exists on the relationship, if any, between gestational performance and melatonin secretion.
Therapeutic supplements thought to target placental blood flow and nutrient delivery to the fetus have been shown to increase fetal growth in animal models of intrauterine growth restriction (IUGR) (50, 52, 64) ; however, few studies have addressed uteroplacental hemodynamics in models of improved fetal growth. Moreover, fetal organ development and functional capacity may be altered by supplementing the dam with melatonin throughout gestation. This is apparent in the sheep fetus that responded to elevated physiological concentrations of melatonin by preventing the norepinephrine-induced contraction of cerebral arteries, lipolysis in brown adipose tissue, and cortisol release from adrenal explants (57) . Interestingly, melatonin receptors have been identified in the developing nephron of human fetal kidneys (13) ; however, an in vivo physiological role of these melatonin receptor pathways within the fetus remains elusive. Recently, melatonin supplementation was shown to negate the decreased birth weight in nutrient-restricted rats (50) , which was attributed to increased placental antioxidant enzyme expression. Therefore, dietary melatonin treatment during a compromised pregnancy may improve placental nutrient transfer capacity, fetal growth, and fetal organ development by decreasing maternal oxidative stress and/or by melatonin receptor mediated pathways. However, the hypothesis that dietary melatonin supplementation will increase uteroplacental blood flow in a compromised pregnancy has yet to be tested. The objectives of the present study were to examine uteroplacental hemodynamics and fetal growth following dietary supplementation with melatonin in an ovine model of IUGR. In addition, fetal organ development and fetal cardiomyocyte maturation and enlargement were examined to determine potential fetal programming that may be associated with maternal melatonin supplementation in an ovine model of IUGR.
MATERIALS AND METHODS
Animal care and use were according to protocols approved by the North Dakota State University Institutional Animal Care and Use Committee.
Animals and experimental design. Nulliparous Western white face ewe lambs were transported to the Animal Nutrition and Physiology Center (ANPC; Fargo, ND) in September of 2010 and were fed to meet nutrient requirements during early gestation. Initially, 64 ewe lambs were placed on pasture with ad libitum access to hay and water with two rams of proven fertility fitted with crayon marking harnesses.
Mating was recorded every 12 h. At day 28 of gestation, dams were transported into a temperature-controlled facility (14°C; ANPC) with a 12:12-h light-dark cycle with lights on at 07:00 and off at 19:00 for the remainder of the study. Breeding dates were intentionally distributed over a large range to decrease the number of dams receiving an ultrasound evaluation per day of gestation, and ranged from September 24, 2010 to December 2, 2010. During days 28 through 35 of pregnancy, ewes were placed in dorsal recumbency, and embryos were enumerated using B mode ultrasonography (Aloka SSD-3500; Aloka America, Wallingford, CT) with a 7.5 MHz, linear transrectal probe, adapted from Schrick and Inskeep (53) . Ewes carrying multiple conceptuses were administered 20 mg im of Lutalyse (Pfizer Animal Health, New York, NY) and reintroduced to the rams 2 wk later. Ewes carrying singleton pregnancies were assigned to treatments and housed in individual pens (0.91 ϫ 1.2 m) at ANPC for the remainder of the experiment. On day 45 of gestation dams were acclimated to a common pelleted diet (Table 1) in a stepwise manner, provided trace mineral salt blocks (4,000 ppm Zn, 1,600 ppm Fe, 1,200 ppm Mn, 325 ppm Cu, 100 ppm I, 40 ppm Co; American Stockman, Overland Park, KS), and ad libitum access to water. Diets were analyzed for dry matter, ash, and crude protein following AOAC (3), and neutral detergent fiber and acid detergent fiber using an Ankom Fiber Analyzer (Ankom Technology, Fairport, NY).
Melatonin and nutritional plane treatments began on day 50 of gestation. Dams were supplemented with 5 mg of melatonin (MEL; Spectrum Chemical Mfg., Gardena, CA) or no melatonin (CON) and provided 100% (ADQ; adequate diet) or 60% (RES; restricted diet) of nutrient recommendations for the remainder of the experiment (2 ϫ 2 factorial design). A total of 32 singleton pregnant ewes were selected for the study; however, one ewe was removed due to a perforated esophagus, which existed prior to dietary treatment. This resulted in four treatment groups consisting of CON-ADQ (n ϭ 7), MEL-ADQ (n ϭ 8), CON-RES (n ϭ 8), or MEL-RES (n ϭ 8). Nutritional requirements were based on NRC (39) recommendations for a 60-kg body wt pregnant ewe lamb during mid-to late-gestation. Adequate ewes were fed to receive adequate nutrients and energy for maintenance, maternal growth, and fetal growth. Feed offered to individual ewes were adjusted based on weekly body weight and body weight change to achieve the desired average daily gain. This mid-to late-gestation maternal undernutrition model has been previously described in our laboratories (30, 34, 44) . This IUGR model has consistently resulted in decreased fetal weight, decreased birth weight, no difference in placental weight, and decreased postnatal growth rates (30, 34, 44) . All ewes were fed and/or supplemented with melatonin-enriched pellets at 14:00 (5 h before the start of the dark cycle at 19:00). Melatonin powder was dissolved in 95% ethanol at a concentration of 5 mg/ml. The day prior to feeding, a subset of the control pellet (100 g) was placed into a small plastic bag and top dressed with 1 ml of melatonin solution. The ethanol was left to evaporate overnight at room temperature with no exposure to light. Melatonin-treated pellets (100 g) were fed to MEL groups at 14:00. All MEL ewes consumed treatments in ϳ5 min. The remainder of the control pellet was given to all groups shortly after consumption of the melatonin-treated pellets.
Maternal body weights were determined prior to 11:00 on a weekly basis. In addition, maternal body condition was scored (1 to 5 scale, with 1 ϭ emaciated and 5 ϭ obese; 34) by two separate evaluators on days 48, 88 , and 124 of gestation (Ϯ0.8 day; mean Ϯ SE). Ultrasound measurements for ewe back fat thickness and longissimus muscle area at the 12th rib were determined using a model 500-SSV (Aloka, Tokyo, Japan) with a linear transducer probe on days 48, 88 , and 124 of gestation (Ϯ0.8 day; mean Ϯ SE).
Melatonin response over 24 h. A preliminary experiment was conducted to test the effects of dietary melatonin supplementation on Blood sampling analysis. Melatonin concentrations were determined using an available melatonin ELISA kit (American Research Products, Belmont, MA) with an analytical sensitivity of 1.6 pg/ml and intra-and interassay coefficients of variation of 9.7% and 9.5%, respectively. The manufacturer reported a cross reactivity of other substances Ͻ 0.01%. The assay was validated for use with sheep serum in our laboratory. Briefly, serum dilutions from two ewes were assayed separately for melatonin and found to be parallel with the standard curve. In addition, serum samples were spiked with chemical-grade melatonin to determine percentage recovery, which was Ͼ 90%. Malondialdehyde (MDA) concentrations were determined using an available TBARS (thiobarbituric acid reactive substances) assay kit (Cayman Chemical, Ann Arbor, MI) with an analytical sensitivity of 0.06 M and intra-and interassay coefficients of variation of 7.7% and 8.1%, respectively.
Color Doppler ultrasonography. Umbilical artery hemodynamics were assessed using a duplex B-mode (brightness mode) and D-mode (Doppler spectrum) program of the color Doppler ultrasound instrument (model SSD-3500; Aloka America, Wallingford, CT) fitted with a 5.0-MHz finger transducer (Aloka UST-672). Ultrasonography examinations started at 15:00 each day and lasted on average 26 min (range ϭ 15 to 64 min) per ewe. All scans ended before the dark phase (19:00). Ultrasound evaluations took place on days 48 (baseline measurements), 50, 60, 70, 80, 90, 100 , and 110 of gestation. Color Doppler ultrasound scans were performed at a constant flow gain setting of 10 and flow filter setting of 2. All dams were scanned transabdominally without the use of anesthesia. Briefly, for each ultrasound examination dams were placed into an elevated crate, the abdomen and leg pit was cleaned with soap and water, and sufficient Aquasonic transmission gel (Parker Laboratories, Fairfield, NJ) was applied to the probe. In B-mode a longitudinal section of the umbilical cord was visualized and the pulsatile umbilical artery was confirmed by switching to a duplex screen containing B-mode imaging and Doppler spectrum waveform plots. Measurements were obtained by placing the sample cursor over the vessel in B-mode while simultaneously recording pulsatile waves in D-mode. The average angle of insonation was 55 Ϯ 1°(SE). Three similar cardiac cycle waveforms from each of three separate ultrasonography evaluations were obtained and averaged per ewe within a gestational day (9 measurements per day). Cardiac cycle waveforms were plotted in D-mode by velocity (cm/s; y-axis) and time (s; x-axis). Fetal heart rate (beats/ min), pulsatility index (PI), resistance index (RI), and blood flow (BF) were calculated using preset functions on the ultrasound instrument. Abbreviations for equations are as follows: peak systolic velocity (PSV), end-diastolic velocity (EDV), mean velocity (MnV), and cross-sectional area of vessel (CSA). Gestational day 130 intraoperative ultrasonography measurements. On day 130 of gestation, dams were weighed and anesthetized with 1.2 ml of 50 mg/ml pentobarbital sodium per 20 kg of body weight at 08:00. Anesthesia was maintained via a jugular catheter. The abdomen was sheared and cleaned with Betadine scrub. The following surgery procedures were nonsurvival; however, aseptic techniques were used to preserve blood and tissues for further laboratory analysis. A catheter was placed into the maternal saphenous artery and advanced to the iliac artery via the femoral artery for monitoring and recording blood pressure throughout the procedure. The uterus was exposed via a midventral laparotomy, covered with warm surgical towels, and liberal amounts of saline (37°C) were applied to the uterus every 5 min. The gravid uterine artery was located and hemodynamics were assessed by color Doppler ultrasonography using the same principals as described under Color Doppler ultrasonography. Intraoperative measurements were recorded by placing the finger transducer next to the uterine artery and prior to the first bifurcation of the uterine artery. After three cardiac cycle waveforms from three separate scans of the gravid uterine artery were recorded, the uterus was turned to locate the nongravid uterine artery. Similarly, three cardiac cycle waveforms from three separate scans were recorded from the nongravid uterine artery. The average angle of insonation for gravid or nongravid uterine artery was 74 Ϯ 2 degrees (mean Ϯ SE). Intraoperative measurements of umbilical artery hemodynamics were recorded by scanning the gravid uterine horn in B-mode until a clear image of the umbilical artery was located. The average angle of insonation for intraoperative umbilical artery blood flow was 61 Ϯ 2 degrees (mean Ϯ SE). Again, three cardiac cycle waveforms from three separate scans of the umbilical artery were recorded in D-mode.
Gestational day 130 measurements. Following the intraoperative umbilical ultrasonography evaluation, the gravid uterine horn was dissected. The umbilical artery was located and blood samples were collected into BD Vacutainer tubes for determination of melatonin and MDA concentrations. Blood was placed on ice and later spun at 2,000 g for 20 min. Serum was stored at Ϫ20°C until further analysis for melatonin or MDA concentrations, respectively. The fetus was removed while under general anesthesia of pentobarbital sodium, which crosses the maternal fetal circulation through the placenta. The fetus was weighed and exsanguinated. Fetal curved crown rump length, biparietal distance, and abdominal girth were recorded. Fetal ponderal index was calculated using the following equation: ponderal index ϭ fetal weight (kg)/curved crown rump length (m) 3 . Fetal organ weight was recorded. In addition to organ weights, kidney length and width (measured at the hilus) were determined for direct comparison to the gestational day 48 to day 110 ultrasound data. Moreover, fetal kidney medullary and cortical widths were assessed via a longitudinal cross section.
Fetal hearts were further processed after the weight was recorded. Briefly, average left and right ventricle thickness was assessed with digital calipers at the base, mid, and top portion of the ventricle. A 1-g sample of the left and right ventricle was collected for cardiomyocyte dissociation. Heart tissue was minced thoroughly in PBS followed by cellular dissociation with three successive 0.05% trypsin in PBS washes for 20 min at 37°C, adapted from Lau et al. (29) . Following incubation, the solution was strained through cheesecloth, and cell pellets were collected by spinning at 500 g for 2 min. Pellets were suspended in PBS, smeared onto slides, and fixed for 10 min in formalin. Slides were then stained with periodic acid-Schiff and hematoxylin stain. Approximately 200 stained cardiomyocytes were counted for each ewe (both left and right ventricle) by two separate evaluators blind to experimental treatment groups. Percentage binucleated cardiomyocytes are reported. The mononucleated and binucleated areas was recorded for 40 cells per ventricle using ImagePro Plus software (version 5.0; Media Cybernetics).
Final ewe body weight was reported as the average body weight measured on days 129 and 130 of gestation, just prior to surgery. Following surgeries, ewes were exsanguinated. Eviscerated ewe weight was calculated as ewe final body weight minus total internal organ weight. Maternal perirenal fat was removed from the kidney and body wall and weighed. Omental and mesenteric fat was stripped from the gastrointestinal tract and weighed together. The uterus was removed at the cervix. Fetal membranes were removed and placentomes were dissected from the uterine wall and counted. Placental caruncular and cotyledonary tissue were separated and weighed.
Statistical analysis. The effects of diet on dependent variables were tested with the MIXED procedure of SAS (SAS software version 9.2, SAS Institute, Cary, NC). Dependent variables measured over time were analyzed using repeated-measures ANOVA of the MIXED procedure of SAS, and means were separated using the PDIFF option of the LSMEANS statement. For maternal serum melatonin concentrations over a 24-h period (preliminary study), the model statement included melatonin treatment, hour, and melatonin treatment by hour interaction. For maternal body condition, umbilical artery hemodynamics, and fetal growth parameters throughout gestation (days 48 to 110), the model statement included: melatonin treatment, nutritional plane, day of gestation, and their respective interactions. Gestational day 130 surgery hemodynamics were analyzed independently from day 48 through day 110 hemodynamic measurements, because of the discrepancy in ultrasonography evaluation in relation to feeding and the use of general anesthesia during the intraoperative measurements. Day 130 surgery and necropsy data were tested using the MIXED procedure of SAS. The model statement included: melatonin treatment, nutritional plane, fetal sex, and melatonin treatment by nutritional plane interaction. Breeding date was used as a covariant due to the range of breeding dates from early September (13.5 h of daylight) to late December (8 h of daylight). Least square means and SE are reported. Statistical significance was declared at P Յ 0.05.
RESULTS
Maternal 24-h melatonin profile. Optimal feeding time in relation to the 12:12-h light-dark cycle was determined after supplementing nonpregnant cycling ewes with 5 mg of melatonin at 14:00 (5 h prior to scotophase; Fig. 1 ). As illustrated in Fig. 1 , maternal melatonin concentrations peaked shortly after feeding and remained elevated (P Ͻ 0.05) in MEL vs. CON during 15:00 and 16:00 of the photophase. Both the amplitude (P Ͻ 0.01) and duration (P Ͻ 0.01) of serum melatonin concentrations were increased in MEL vs. CON ewes. Similar concentrations of melatonin were observed during the scotophase as well as the prefeeding photophase.
Maternal body condition throughout gestation. No main effects of melatonin treatment or interactions with melatonin treatment were observed for maternal dry matter intake, maternal body weight, body condition score, loin muscle area, or back fat thickness. Maternal dry matter intake was decreased in RES (453 Ϯ 6 g) vs. ADQ (791 Ϯ 6 g) fed dams. Maternal body weight on day 50 of gestation was not different between treatments and averaged 45.6 Ϯ 0.5 kg. A nutritional plane by gestational day interaction (P Ͻ 0.001) was observed for maternal body weight from days 48 to 130 of gestation ( Fig. 2A) . Average daily gain was increased (P Ͻ 0.0001) in ADQ (85 Ϯ 7 g/day) vs. RES (Ϫ49 Ϯ 7 g/day) dams. A nutritional plane by gestational day interaction (P Ͻ 0.001) was observed for maternal body condition score (Fig. 2B) , where RES dams showed a decrease in body condition score at days 88 and 124 of gestation compared with ADQ dams. A nutritional plane by gestational day interaction was observed for maternal loin muscle area (Fig. 2C) , where RES dams showed a decrease (P Ͻ 0.05) in loin muscle area at day 124 of gestation compared with ADQ dams. Maternal back fat thickness was not altered by nutritional plane; however, a main effect of gestational day (P Ͻ 0.01) revealed a decrease in back fat thickness (Fig. 2D) for all groups at day 124 of gestation compared with days 48 and 88.
Umbilical artery hemodynamics throughout gestation. Umbilical artery blood flow across all treatment groups from days 48 to 110 of gestation are illustrated in Fig. 3A . Means were not separated due to the lack of a melatonin treatment by nutritional plane by gestational day interaction (P ϭ 0.15; Fig. 3A) . However, we did observe a significant melatonin treatment by day interaction (P Ͻ 0.001) for umbilical artery blood flow (Fig. 3B) , which was increased (P Ͻ 0.05) in MEL dams from day 60 through day 110 of gestation compared with CON dams. Moreover, at day 110 of gestation, MEL dams had a 20% increase in umbilical artery blood flow compared with CON dams. In addition, a significant nutritional plane by day interaction (P Ͻ 0.0001) was observed for umbilical artery blood flow (Fig. 3C) , which was decreased (P Ͻ 0.05) in RES dams from day 80 through day 110 of gestation compared with ADQ dams. Moreover, at day 110 of gestation, RES dams had a 23% decrease in umbilical artery blood flow compared with ADQ dams. Umbilical artery PI and RI were analyzed as percentage change from baseline measurements (day 48 of gestation). A main effect of gestational day (P Ͻ 0.001) was observed for percentage change in umbilical artery PI (Fig. 4A) , which increased from day 50 to day 60 of gestation, followed by a rapid decline from day 80 to day 110 of gestation. A similar gestational day pattern was observed for percentage change in umbilical artery RI (Fig. 4B) . Moreover, percentage change in umbilical artery RI showed a melatonin treatment by nutritional plane by gestational day interaction (P Ͻ 0.05), where CON-RES dams had decreased RI compared with MEL-RES dams at day 60 of gestation and CON-RES dams had decreased RI compared with the other groups at day 100 of gestation. No other differences among groups within a gestational day were observed for percentage change in umbilical artery RI. Average placentome diameter showed a melatonin treatment by nutritional plane by gestational day interaction (P Ͻ 0.05), where MEL-ADQ dams were increased compared with other groups on day 60 of gestation and MEL-RES dams were increased compared with CON-RES dams on day 110 of gestation.
Fetal growth throughout gestation. Fetal growth parameters measured via ultrasonography throughout gestation are illustrated in Fig. 5 . We did not observe any melatonin treatment by nutritional plane by gestational day interactions for fetal growth parameters. A nutritional plane by gestational day interaction (P Ͻ 0.01) was observed for fetal abdominal diameter, which remained similar between treatments until day 110 of gestation when fetuses from RES dams were decreased by 9% compared with fetuses from ADQ dams (Fig. 5A) . There was no difference in abdominal diameter between fetuses from MEL and CON dams. Fetal biparietal distance showed a melatonin treatment by gestational day interaction, where fetuses from MEL dams were increased by 9% compared with fetuses from CON dams (Fig. 5B) . There was no difference in biparietal distance between fetuses from RES and ADQ dams. Both fetal kidney length and width revealed a melatonin treatment by gestational day interaction (P Ͻ 0.05), where fetuses from MEL dams had increased kidney dimensions at days 90, 100, and 110 of gestation compared with fetuses from CON dams (Fig. 5, C and D) . At day 110 of gestation, fetal kidney length and kidney width were both increased in fetuses from MEL vs. CON dams by 12% and 19%, respectively. There was no difference in fetal kidney length or width between fetuses from RES and ADQ dams.
Melatonin profiles and oxidative stress. Maternal and fetal concentrations of melatonin and MDA are illustrated in Fig. 6 . Maternal concentrations of melatonin at 23:00 showed a melatonin treatment by gestational day interaction (P Ͻ 0.001; Fig.  6A ), where scotophase concentrations of melatonin remained similar in CON dams throughout gestation and increased in MEL dams at days 84 and 124 of gestation. There was no difference in maternal scotophase concentrations of melatonin between RES and ADQ dams. Umbilical artery concentrations of melatonin at day 130 of gestation ( Fig. 6B ) were elevated (P Ͻ 0.001) in MEL vs. CON dams. Maternal MDA concentrations, an indicator of lipid peroxidation, remained similar from day 48 to day 90 of gestation and then increased (P Ͻ 0.01) on day 120 of gestation ( Fig. 6C) . No effect of melatonin treatment or nutritional plane was observed for either maternal jugular vein or fetal umbilical artery MDA concentrations (Fig.  6, C and D) .
Uteroplacental hemodynamics at day 130 of gestation. Intraoperative uteroplacental hemodynamics on day 130 of gestation are illustrated in Table 2 . Umbilical artery blood flow was increased (P Ͻ 0.05) by 17% in MEL vs. CON dams (Table 2 ). Umbilical artery CSA was increased (P ϭ 0.01) by 25% in MEL vs. CON dams. Fetal heart rate, umbilical artery blood flow relative to fetal weight, and umbilical artery PI, RI, and CSD were not affected (P Ն 0.06) by melatonin treatment or nutritional plane.
A main effect of nutritional plane (P Ͻ 0.05) was observed for gravid uterine artery blood flow on day 130 of gestation, which was decreased by 22% in RES vs. CON (Table 2 ). A melatonin treatment by nutritional plane interaction was observed for gravid uterine artery RI (P Ͻ 0.05), which was increased in MEL-RES vs. MEL-ADQ dams. A melatonin treatment by nutritional plane interaction was observed for both nongravid uterine artery PI (P Ͻ 0.05) and RI (P Ͻ 0.05). The nongravid uterine artery PI was decreased in MEL-ADQ vs. CON-ADQ dams. Nongravid uterine artery RI was decreased in MEL-ADQ vs. CON-ADQ and MEL-RES dams. Total uterine artery blood flow (gravid ϩ nongravid) showed a main effect of nutritional plane (P Ͻ 0.05), where total blood Baseline measurements were taken on day 48 of gestation and treatments began on day 50 of gestation. A: individual groups. The 3-way interaction of melatonin treatment by nutritional plane by day was not significant (P ϭ 0.15). Significant interactions were observed for melatonin treatment by day (B; P Ͻ 0.001) and nutritional plane by day (C; P Ͻ 0.0001). *Difference (P Ͻ 0.05) between means within the same time point. Values are means Ϯ SE.
flow was decreased by 23% in RES vs. ADQ dams. Maternal heart rate, maternal blood pressure, gravid uterine artery blood flow relative to fetal weight, and gravid and nongravid uterine artery CSD and CSA as well as absolute nongravid uterine artery blood flow were not affected (P Ն 0.08) by melatonin treatment or nutritional plane. Table 3 . Ewe body weight and ewe eviscerated weight were decreased in RES vs. ADQ dams (P Ͻ 0.005). Maternal perirenal fat and perirenal fat by body weight was decreased in RES vs. ADQ dams (P Ͻ 0.001). Maternal omental and mesenteric fat as well as omental and mesenteric fat by body weight were decreased in RES vs. ADQ dams (P Ͻ 0.001). Empty uterine weight was decreased (P Ͻ 0.001) in RES vs. ADQ dams, while total placentome weight, caruncle weight, cotyledon weight, and placentome number were not different between groups.
Ewe measurements at day 130 of gestation. Maternal measurements at necropsy on day 130 of gestation are illustrated in
Fetal measurements at day 130 of gestation. Fetal growth parameters at necropsy on day 130 of gestation are illustrated in Table 4 . There was a main effect of nutritional plane (P Ͻ 0.001) on fetal weight, which was decreased by 12% in fetuses from RES vs. ADQ dams. Fetal eviscerated weight was also decreased by 12% in fetuses from RES vs. ADQ dams. Fetal curved crown rump length was not different between groups. A melatonin treatment by nutritional plane interaction was observed for both fetal ponderal index (P Ͻ 0.05) and fetal abdominal girth (P Ͻ 0.01), which was increased for both variables in fetuses from MEL-ADQ dams vs. all other groups.
Fetal biparietal distance was decreased in fetuses from CON-RES vs. CON-ADQ dams, while fetuses from MEL-RES dams were similar (P Ͼ 0.50) to fetuses from CON-ADQ dams.
Fetal organ weights on day 130 of gestation are illustrated in Table 5 . Fetal brain weights were not different between treatment groups; however, fetal brain weight relative to fetal weight showed a main effect of nutritional plane (P Ͻ 0.01), which was increased in fetuses from RES vs. ADQ dams. Fetal lung weight was decreased in RES vs. ADQ dams, while lung weight relative to fetal weight was not different between treatment groups. Absolute and relative adrenal weights were not different between treatment groups. Fetal kidney weight was not affected by melatonin treatment or nutritional plane. Kidney weight relative to fetal weight was increased in MEL-RES vs. MEL-ADQ dams. Kidney length was increased (P Ͻ 0.05) in fetuses from MEL vs. CON dams, while kidney width was not different among groups. No effects were observed for P values are main effect of melatonin supplementation (Trt), main effect of nutritional plane (Nut), or the interaction between melatonin supplementation by nutritional plane (Trt*Nut). CON, control; ADQ, adequate; RES, restricted; MEL, melatonin; HR, heart rate; UM, umbilical artery; BF, blood flow; FW, fetal weight; PI, pulsatility index; RI, resistance index; CSD, vessel cross-sectional diameter; CSA, vessel cross-sectional area; BP, blood pressure; and UT, gravid or nongravid uterine artery. Means with different letter subscripts depict differences P Ͻ 0.05. Fetal heart measurements at day 130 of gestation. Fetal heart development and maturation rate is illustrated in Table 6 . Fetal heart weight, heart weight relative to fetal weight, left and right ventricle thickness, and percentage cardiomyocyte binucleation were not different between treatment groups. Cardiomyocyte enlargement is illustrated in Fig. 7 . For the left ventricle, mononucleated cardiomyocyte area was increased in fetuses from CON-RES vs. CON-ADQ and MEL-RES dams (Fig. 7B) . Left ventricle binucleated area was increased in CON-RES and MEL-ADQ vs. CON-ADQ dams (Fig. 7B) . Similar results were found when left ventricle cardiomyocyte area was expressed relative to fetal heart weight ( Fig. 7C) . For the right ventricle, mononucleated cardiomyocyte area was not different between treatment groups (Fig. 7D) . Right ventricle binucleated area was increased in fetuses from CON-RES, MEL-ADQ, and MEL-RES vs. CON-ADQ dams (Fig. 7D) . Similar results were found when right ventricle cardiomyocyte area was expressed relative to fetal heart weight (Fig. 7E) .
DISCUSSION
In the present study, maternal body weight, body condition, loin muscle area, and fat mass were decreased in our ovine Curved crown rump (CCR). Eviscerated fetal weight ϭ fetal weight Ϫ total internal organ weight. Means with different letter subscripts depict differences P Ͻ 0.05. model of IUGR. In addition, no main effects or interactions of melatonin supplementation were observed for variables pertaining to maternal body condition throughout gestation. These are important observations due to the behavioral changes that occur in response to melatonin administration, which has been associated with sedation, hypnotic activity, pain perception threshold elevation, and anti-anxiety effects in several species (22) . Therefore, melatonin treatment could potentially decrease locomotor activity. In addition, the dietary dosage of melatonin needed to alter behavior (i.e., sedation, hypnotic activity, and/or anti-anxiety effects) is much higher compared with doses required for altering endocrine profiles. The analgesic properties of melatonin are observed at dosages of 20 -200 mg/kg of body weight (22) , while the present experiment treated ewes at ϳ100 g/kg body weight. This study did not examine the effects of melatonin on maternal behavior during gestation; however, if our present dosage had any analgesic properties this was not congruent with any alterations in ewe body condition following dietary supplementation with melatonin. In addition, ultrasonography was performed on all ewes throughout gestation and ϳ1 to 3 h postmelatonin treatment. During these examinations we did not visually observe any differences in ewe activity and all ewes appeared alert postfeeding.
In the present study, melatonin treatment increased umbilical artery blood flow from day 60 through day 110 of gestation. In addition, the main effect of melatonin treatment on umbilical artery blood flow was still apparent under general anesthesia at day 130 of gestation. Similar to our own results, Thakor et al. (55) reported a 20% increase in umbilical artery blood flow after infusing physiological levels of melatonin into sheep fetuses during late gestation. This report examined umbilical artery blood flow with Transonic flow probes during a short window of late gestation. In the present experiment, the use of Doppler ultrasonography allowed for continual evaluation of blood flow throughout mid to late gestation and during growth of the fetus, placenta, and umbilical artery. In addition, fetal growth parameters and placental growth were monitored alongside umbilical blood flow measurements. We observed a dramatic increase in placentome diameter until day 70 of gestation after which diameter plateaued, while fetal growth and umbilical blood flow continued to increase throughout gestation. It is important to note that both umbilical artery PI and RI began to decrease shortly after placentome diameter reached its maximum size (ϳday 70 to 80 of gestation). These results corroborate previous reports that exponential growth of the fetus during the last half of gestation are dependent upon increasing uteroplacental blood flow and placental vascularity, since the placenta reaches its maximum size during the first two-thirds of gestation (18, 33, 43, 48, 49) . Maternal nutrient restriction decreased umbilical artery blood flow from day 80 through day 110 of gestation; however, this effect was no longer apparent during the intraoperative blood flow measurements on day 130 of gestation. These discrepancies could be related to the time of feeding in relation to ultrasonography evaluation of umbilical artery blood flow. Intraoperative uterine artery blood flow was decreased by nutrient restriction on day 130 of gestation, which is similar to other reports of aberrations in uterine blood flow and hemodynamics during IUGR in various species (7, 8, 15, 28, 62) . Melatonin treatment did not affect uterine artery blood flow; however, a significant melatonin treatment by nutritional plane interaction was observed for uterine artery PI and RI. These indices of uterine arterial pulsatility and resistance were typically increased in MEL-RES vs. MEL-ADQ dams. Previous reports have indicated that uterine artery PI is a sufficient predictor of human IUGR; however, new insights from Ferrazzi et al. (15) showed that uterine artery blood flow volume was severely decreased in compromised pregnancies, while false-positive tests have been observed when predicting human IUGR based solely on uterine artery PI. It is important to note that day 130 ultrasonography measurements were recorded under general anesthesia, which may interfere with blood flow volume. However, for the present experiment all animals underwent the same procedures and dosages of anesthesia and several of the hemodynamic parameters showed treatment effects during intraoperative evaluations.
In the present experiment, uterine artery blood flow was decreased by maternal nutrient restriction, while umbilical artery blood flow was increased by melatonin treatment. The previous work by Thakor et al. (55) showed that the melatonininduced increase in umbilical artery blood flow was blocked by providing a nitric oxide clamp. Melatonin receptors have been identified throughout the cardiovascular system (heart, coronary arteries, cerebral arteries, and caudal arteries) and activation of melatonin receptor 1 or 2 has been associated with vasoconstriction or vasodilatation (40) . Melatonin-induced vasodilation can be mediated by endothelial cell-specific melatonin receptors, which activate nitric oxide synthase leading to vasodilation (41) . However, melatonin receptors localized to vascular smooth muscle cells result in vasoconstriction, via decreased intracellular cAMP and increased intracellular calcium (41) . Melatonin has previously been reported to have strong antioxidant properties (42), whereby melatonin can stimulate glutathione peroxidase activity and scavenge peroxyl radicals generated during lipid peroxidation (46) . Therefore, independent of melatonin receptor expression, melatonin may decrease reactive oxygen species within the vasculature, which also causes increased endothelial cell nitric oxide synthase or increased bioavailability of nitric oxide with in the vasculature (41) . In the present study, if both the uterine and umbilical artery were under increased oxidative stress during nutrient restriction, apart from detectable MDA concentrations measured at day 130, then we would expect an increase in vasodilation in both vessels following extended antioxidant exposure of melatonin. Therefore, due to the absence of a melatonin treatment effect on uterine artery blood flow; the umbilical artery-specific vasodilation in the present study may be partially mediated through melatonin receptor-specific pathways located in the umbilical artery or fetal portion of the placenta. Presently our laboratory has preliminary data showing that both the maternal and fetal portions of the day 130 sheep placenta abundantly express melatonin receptor 2 (31). However, melatonin receptor expression and localization within the uteroplacental vasculature will need to be further characterized to unravel the specific alterations in umbilical artery hemodynamics in sheep following melatonin supplementation. These pathways may be mediated via melatonin receptors localized to endothelial cells or vascular smooth muscle cells, via decreased vascular bed oxidative stress, or a combination of these pathways.
A main effect of nutritional plane was observed for fetal weight at day 130 of gestation. Moreover, the melatonin treatment by nutritional plane interaction (Table 4 ; P ϭ 0.07) tended to show a greater difference in fetal weight between MEL dams vs. CON dams, which was not due to a difference in fetal weight between CON-RES and MEL-RES dams, but rather an increase in fetal weight between MEL-ADQ vs. CON-ADQ dams. Rats supplemented with melatonin had no effect on late gestation fetal weight, while birth weights were increased in nutrient-restricted rats supplemented with melatonin compared with adequately fed groups (50). However, major differences occur in fetal and placental development between the litter-bearing altricial rat vs. the precocial singleton-bearing ewe. Presently, no report exists on fetal growth parameters, apart from rat pup weights, following maternal supplementation with melatonin. Interestingly, we found increased abdominal girth and ponderal index in fetuses from MEL-ADQ dams vs. all other treatment groups. The measurement of ponderal index has been used to distinguish fetal weight from disproportionate fetal growth, which is an important indicator of IUGR. Offspring that are thin at birth (low ponderal index) have an increased incidence of insulin resistance and cardiovascular disease in adult life (4, 5, 21, 24) . Moreover, fetal sheep undergoing chronic placental embolization had disproportionate fetal growth (lower ponderal index) that was associated with hypertension and cardiac hypertrophy (37) . Interestingly, fetal biparietal distance, another important indicator of fetal growth was altered by melatonin supplementation. To our knowledge, this is the first report of a therapeutic disproportionately rescuing fetal biparietal distance, while not rescuing fetal weight in a model of IUGR. Epidemiological studies have shown that adult male mortality rate from cardiovascular disease was lower with increasing head circumference at birth (4). Therefore, melatonin supplementation during gestation may be a beneficial model of developmental program-ming for animals born with disproportionate fetal growth and head circumference.
Brain weight relative to fetal weight showed a significant effect of nutritional plane, with the fetal brain being spared in RES dams vs. ADQ dams. These results are similar to other reviews on IUGR where fetal cardiac output is redistributed to increase blood flow to the brain (36) . Similar to the ultrasound data, both fetal kidney length and width were increased in fetuses from MEL dams compared with CON dams. These differences in kidney dimensions were not due to disproportionate development of the kidney cortex or medulla. Altered fetal kidney dimensions, such as broader neonatal kidneys (decreased length by width dimension), have been associated with abnormalities in the kidney renin-angiotensin system, which may lead to later life hypertension (63) . Interestingly, melatonin receptors 1 and 2 have been specifically localized to the early developing and differentiating nephrons of the human fetal kidney (13) , which may be important for early nephrogenesis. Therefore, nephron number, as well as function, may be altered in neonates exposed to elevated melatonin in utero that could lead to altered vascular resistance, blood pressure, and renal failure in the adult animal, which warrants further examination in the offspring. Alterations in fetal heart right and left ventricular weights have been reported following maternal undernutrition (59) . Sheep fetal cardiomyocyte maturation, enlargement, and proliferation have been previously characterized throughout gestation (25) . Moreover, intrauterine growth restriction during late gestation altered the vasoreactivity of the coronary arteries and cardiomyocyte maturation rate in fetal sheep, which may be indicative of later life cardiovascular dysfunction (9) . In the present study, cardiomyocyte maturation, determined by percentage binucleation, was not different between treatment groups; however, cardiomyocyte enlargement was significantly altered in both the left and right ventricles, whereby maternal nutrient restriction increased cardiomyocyte area. Interestingly, maternal melatonin supplementation in nutrient-restricted dams may reverse the left ventricular cardiomyocyte enlargement; however, binucleated cells from the right ventricle were enlarged in fetuses from melatonintreated dams regardless of nutritional plane. Similar to the alterations in fetal kidney dimensions and cardiomyocyte enlargement, the observed melatonin treatment by nutritional plane interaction for fetal small intestinal mass may also be melatonin receptor specific. Apart from the pineal gland, the enzymes responsible for melatonin synthesis (N-acetyltransferase, hydroxyindole-O-methyltransferase) are also located in the gastrointestinal tract of several mammalian species (10). In the adult animal, elevated gastrointestinal melatonin has been associated with increased mucosal blood flow, decreased peristalsis, and regulation of fecal water content (10) . Presently, no report exists on fetal gastrointestinal melatonin synthesis; however, the present study shows that extended periods of elevated melatonin within the fetus alters small intestine weight.
In the present study, we observed similar scotophase concentrations of melatonin throughout gestation in CON dams (Fig. 6A ) compared with nonpregnant cycling CON ewes (Fig.  1) . These data are in contrast to previous reports in human studies where scotophase melatonin concentrations are increased nearly twofold during the last trimester of pregnancy compared with mid-pregnancy or nonpregnant females (38) . Moreover, scotophase melatonin concentrations are increased nearly 50% in humans carrying twin vs. singleton pregnancies, while severely compromised pregnancies have a 50% reduction (38) . In our ovine model of IUGR, nighttime melatonin concentrations were not different between ADQ and RES dams. In the present experiment, we observed elevated umbilical artery melatonin concentrations nearly 18 h after supplementing the dam with dietary melatonin. Interestingly, in both rats and sheep fetal melatonin concentrations are dependent on maternal melatonin production or supplementation of melatonin through the diet (32, 54) . Previous reports have characterized fetal circulation of melatonin in sheep, which was markedly different from the dam in relation to amplitude but not duration (65) . The amplitude of fetal concentrations of melatonin during the scotophase was reduced in relation to the dam's scotophase amplitude, while fetal concentrations of melatonin during the photophase remained approximately twofold above the dam's photophase concentrations. In addition, the diurnal rhythm of melatonin concentrations in the fetus closely resembled that of the dam, with the exception of a 30 -60 min delay in the nocturnal rise of fetal concentrations in relation to the dam (65) .
Melatonin has been reported to alter both steroid and prostaglandin metabolism in sheep, which could impact both uteroplacental blood flow and fetal blood distribution during extended periods of melatonin exposure. Melatonin treatment increased progesterone production in luteal cell cultures (60), while melatonin treatment decreased prostaglandin F2␣ and E2 in endometrial and hypothalamic cultures (2, 11) . In addition, melatonin treatment in rats caused a 59% decrease in uterine estrogen receptors and a 35% increase in uterine progesterone receptors, as well as a reduction in uterine contractile response to oxytocin compared with controls (1). In human breast cancer cell lines, melatonin has been shown to interact with estrogen receptors (selective estrogen receptor modulator), and it has been implicated in reducing estrogen synthesis in steroidogenic tissues (selective estrogen enzyme modulator; 12). Melatonin has been shown to reduce the activity and expression of enzymes responsible for the synthesis and bioavailability (aromatase and sulfatase) of estrogens and increase the activity and expression of estrogen sulfotransferase (generating an estrogen sulfate with low biological activity and a long half-life; 12). These results are important to the present research because uteroplacental steroid and prostaglandin synthesis and metabolism are associated with nutrient transport capacity and uterine blood flow (17, 47) . In addition, estrogen has been implicated in blocking adrenergic uterine arterial tone (18) and elevated melatonin may be implicated in decreasing estrogen concentrations or estrogen sensitivity, which has direct implications in controlling uterine blood flow during compromised pregnancies. In addition to the potential alterations in steroid and prostaglandin concentrations following melatonin supplementation, the observed alteration in umbilical blood flow and the disproportionate fetal growth following melatonin supplementation may be mediated through specific melatonergic receptors. These pathways are relevant in the fetus, where the addition of physiological concentrations of melatonin prevented the vasoconstriction caused by norepinephrine in lateterm fetal sheep cerebral arteries (57) . It is interesting to note that fetal cardiac output and blood flow distribution may be altered via arterial melatonergic receptor pathways within the developing fetus, which could lead to disproportionate fetal growth. However, future investigations are needed to evaluate fetal blood flow distribution following long-term melatonin supplementation.
Perspectives and Significance
Low birth weight offspring have an increased incidence of adult onset diseases (6), poor growth rates, and lower daily rates of gross energy accretion (23) . Compromised pregnancies have shown aberrations in uterine blood flow, umbilical blood flow, and placental vascularity, which is highly associated with the magnitude of fetal growth restriction. The present experiment provides evidence of improved umbilical cord blood flow in animals treated daily with dietary melatonin, while melatonin treatment did not appear to affect uterine artery blood flow. Therefore, melatonin treatment may be used to negate the consequences of IUGR during specific abnormalities in umbilical blood flow as long as sufficient uterine blood perfusion is maintained during the pregnancy. The use of Doppler ultrasonography throughout gestation to monitor umbilical blood flow, allowed us to conclude that dietary melatonin exposure increased blood flow after 10 days of treatment. These specific melatonin responses on umbilical artery hemodynamics may be partially mediated through vascular melatonin receptors, and presently we are examining maternal and fetal placental artery vascular reactivity following dietary melatonin supplementation. Although, melatonin treatment did not rescue fetal weight in nutrient-restricted ewes; we did observe disproportionate fetal growth and fetal organ development. Melatonin receptors have been discovered throughout the cardiovascular system, and extended activation of these melatonergic pathways within the fetus may result in altered blood flow distribution during important time points of development. This is evident in the altered fetal kidney development, cardiomyocyte enlargement, and small intestinal mass within melatonin-supplemented animals; however, offspring performance following elevated in utero exposure to melatonin still needs to be examined. In addition, maternal dietary melatonin treatment could be used to study neonatal outcome associated with disproportionate fetal growth.
